# Amino Acid Supplementation in Continuous Renal Replacement Therapy

> **NCT06835816** · NA · RECRUITING · sponsor: **Karolinska University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DIETARY_SUPPLEMENT:** Amino acid supplementation (Glavamin, Fresenius Kabi)

## Key facts

- **NCT ID:** NCT06835816
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06835816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06835816, "Amino Acid Supplementation in Continuous Renal Replacement Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06835816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
